# Sutro Biopharma, Inc.: Form 8-K, filed Nov 8, 2018

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2018-11-08
- Accepted by EDGAR: Nov 8, 2018, 17:09 ET
- Period: 2018-11-08
- Accession: 0001193125-18-322690
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000119312518322690/d651502d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000119312518322690/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000119312518322690/d651502d8k.htm

Filed Nov 8, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-322690. Last ingested by Listed: Nov 9, 2026, 23:14 ET. No prices; not investment advice.